Preexisting medical conditions should be considered before prescribing clozapine. Ongoing education on medication and mental illness for patients and family members is essential to prepare them for adherence to management plans. Healthcare providers are responsible for monitoring the side effects of clozapine.

The purpose of this project was to evaluate the service delivery (i.e., attendance rate) of a buprenorphine management treatment program and compared patient recovery-related information between service methods. This is a chart review and cross-sectional comparison of pre- versus post-COVID 19 data. In the sample of 28 adults, there was no significant difference in mean attendance rates pre- (99.46%) vs. during-pandemic (96.13%) ( t =1.92, p =0.07). There was a significant difference in patient participation in therapy pre- and during-pandemic ( Χ 2 =1.98, p =0.03). The use of telemental health services, within a BMT program, may be a viable option when normal in-person services are disrupted.

No abstract

No abstract